| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 14:00-14:07 |
Prediction Model of Survival in Unresectable HCC with Central Bile Duct Invasion Receiving TACE after Biliary Drainage: TEMP Score |
Wen-Zhe Fan | The First Affiliated Hospital, Sun Yat-Sen University, China |
| 2 | 14:07-14:14 |
Thermosensitive Nanogel: A Novel Embolic Agent of TACE for HCC |
Rong Ding | Yunnan Provincial Cancer Hospital, China |
| 3 | 14:14-14:21 |
Effect of AFP and PIVKA-II Secretion Status on Prognosis of Advanced HCC Patients Receiving TACE plus Systemic Therapies |
Jin-Feng Bai | Yunnan Provincial Cancer Hospital, China |
| 4 | 14:21-14:28 |
TACE Combined with Systemic Therapy for Unresectable Liver Cancer |
Ning Ai | The Fourth Hospital of Hebei Medical University, China |
| 5 | 14:28-14:35 |
TACE and TKIs with or without PD-1 as First-line Treatment for Unresectable HCC: A Propensity Score Matching Study |
Xue-Gang Yang | Sichuan Cancer Hospital & Institute, China |
| 6 | 14:35-14:42 |
MWA vs. RFA Combined with Vertebroplasty for Vertebral Metastatic Tumors: A Retrospective Cohort Study |
Fu-An Wang | Jiangsu Subei People's Hospital, China |
| 7 | 14:42-15:00 |
Panelists
Hai-Dong Zhu
Zhongda Hospital, Southeast University, China
Alex Tang Subang Jaya Medical Centre,Malaysia Wen-Zhe Fan The First Affiliated Hospital, Sun Yat-Sen University, China Rong Ding Yunnan Provincial Cancer Hospital, China Jin-Feng Bai Yunnan Provincial Cancer Hospital, China Ning Ai The Fourth Hospital of Hebei Medical University, China Xue-Gang Yang Sichuan Cancer Hospital & Institute, China Fu-An Wang Jiangsu Subei People's Hospital, China Jian-Bo Zhao Southern Hospital of Southern Medical University, China |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 15:00-15:07 |
Fruquintinib Combined with Sintilimab plus TACE for Unresectable HCC: A Single-arm Phase 2 Study |
Hui Zeng | Zhejiang Provincial Cancer Hospital, China |
| 2 | 15:07-15:14 |
Predictive Model of Unresectable HCC Treated with TACE-HAIC Combined with TKIs and ICIs |
Li-Nan Yin | Harbin Medical Univisity Cancer Hospital, China |
| 3 | 15:14-15:21 |
Transformation of IR Workflow through Smart Operating Room Development: Technological Integration and Clinical Practice |
Lin Zhu | Zhongshan Hospital Affiliated with Fudan University, China |
| 4 | 15:21-15:28 |
Can Commonly Used Large Language Models Be Recommend Interventional Therapy to Liver Cancer Patients? |
Zhi-Hui Chang | Shengjing Hospital of China Medical University, China |
| 5 | 15:28-15:35 |
Association between TACE Refractoriness and Prognosis in Chinese Patients with HCC: A Retrospective Cohort Study |
Qin-Xue Sun | Ningbo Medical Center Li Huili Hospital, China |
| 6 | 15:35-16:00 |
Panelists
Hyun Ki Yoon
Asan Medical Center, University of Ulsan College of Medicine, Korea
Prijo Sidipratomo Dr. Cipto Mangunkusumo National General Hospital, Universitas Indonesia, Indonesia Hui Zeng Zhejiang Provincial Cancer Hospital, China Li-Nan Yin Harbin Medical Univisity Cancer Hospital, China Lin Zhu Zhongshan Hospital Affiliated with Fudan University, China Zhi-Hui Chang Shengjing Hospital of China Medical University, China Qin-Xue Sun Ningbo Medical Center Li Huili Hospital, China |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 16:00-16:10 |
Passing the Torch Mentoring Program: Introduction |
Ho-Young Song | Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China |
| 2 | 16:10-16:20 |
Passing the Torch Mentoring Program: Leading Mission I |
Hang Yuan | Henan Cancer Hospital, China |
| 3 | 16:20-16:30 |
Passing the Torch Mentoring Program: Leading Mission II |
Bing-Jie Zheng | Henan Cancer Hospital, China |
| 4 | 16:30-16:40 |
Passing the Torch Mentoring Program: Leading Mission IIIa |
Hang Yuan | Henan Cancer Hospital, China |
| 5 | 16:40-16:50 |
Passing the Torch Mentoring Program: Leading Mission IIIb |
Shi-Jun Xu | Henan Cancer Hospital, China |
| 6 | 16:50-17:00 |
Passing the Torch Mentoring Program: Leading Mission IV |
Hong-Tao Hu | Henan Cancer Hospital, China |
| 7 | 17:00-17:10 |
Passing the Torch Mentoring Program: Leading Mission V |
Xi Li | The Fifth Affiliated Hospital of Sun Yat-sen University, China |
| 8 | 17:10-17:20 |
Passing the Torch Mentoring Program: Leading Mission VI |
Ho-Young Song | Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China |
| 9 | 17:20-18:00 |
Q & A and Panel Discussion (Overcoming Miscommunication & Shaping the Future)
Jiaywei Tsauo
Guangdong Provincial People's Hospital, China
Bin-Yan Zhong Zhejiang Cancer Hospital, China |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 14:00-14:30 |
How to Get Your Paper Published |
Jiaywei Tsauo | Guangdong Provincial People's Hospital, China |
| 2 | 14:30-14:45 |
The Art of Transforming Ideas into Scientific Investigations |
Bin-Yan Zhong | Zhejiang Cancer Hospital, China |
| 3 | 14:45-15:00 |
How I Updated My Writing Skills after Publishing My First Paper |
Chu Hui Zeng | Zhongda Hospital Southeast University, China |
| 4 | 15:00-15:15 |
Top Five Reasons for Writing Scientific Papers |
Ho-Young Song | Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China |
| 5 | 15:15-15:55 |
Panelist
Ho-Young Song
Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China
Jiaywei Tsauo Guangdong Provincial People's Hospital, China Chu Hui Zeng Zhongda Hospital Southeast University, China Bin-Yan Zhong Zhejiang Cancer Hospital, China Jian Lu Zhongda Hospital, Southeast University, China Xi Li The Fifth Affiliated Hospital of Sun Yat-sen University, China |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 16:00-16:12 |
Sequential TACE and PVE before Right Pemihepatectomy in Patients with HCC |
Hyun Ki Yoon | Asan Medical Center, University of Ulsan College of Medicine, Korea |
| 2 | 16:12-16:24 |
Surgical Treatment of HCC with Portal Vein Tumor Thrombus - Progress and Perspectives |
Shu-Qun Cheng | Eastern Hepatobiliary Surgery Hospital, China |
| 3 | 16:24-16:36 |
TARE for Unresected HCC with Portal Vein Invasion: Which Patient to Treat? |
Ajit K. Yadav | Sir Ganga Ram Hospital, Delhi, India |
| 4 | 16:36-16:48 |
Precision Radiotherapy and Immune-targeted Therapeutic Strategies in Hepatocellular Carcinoma |
Wei-Hu Wang | Beijing Cancer Hospital, China |
| 5 | 16:48-17:00 |
ICIs and Anti-VEGF Antibody/TKIs with or without TACE as First-line Treatment for Advanced HCC (CHANCE2201): A Target Trial Emulation Study |
Hai-Tao Zhao | Peking Union Medical College Hospital, China |
| 6 | 17:00-17:12 |
A Nationwide Target Trial Emulation on the Treatment of Patients with HCC and Main Trunk PVTT Using 125I Irradiation Stents and Combined Therapeutic Approaches (PATENCY II) |
Jian Lu | Zhongda Hospital, Southeast University, China |
| 7 | 17:12-17:30 |
Panelists
Flavio G. Rocha
Oregon Health and Science University, USA
Hyun Ki Yoon Asan Medical Center, University of Ulsan College of Medicine, Korea Shu-Qun Cheng Eastern Hepatobiliary Surgery Hospital, China Ajit K. Yadav Sir Ganga Ram Hospital, Delhi, India Wei-Hu Wang Beijing Cancer Hospital, China Hai-Tao Zhao Peking Union Medical College Hospital, China Jian Lu Zhongda Hospital, Southeast University, China |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 13:00-13:10 |
Open Remarks
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
|
||
| 2 | 13:10-13:30 |
ISMIO Work Report |
Hai-Dong Zhu | Zhongda Hospital, Southeast University, China |
| 3 | 13:30-13:55 |
General discussion |
||
| 4 | 13:55-14:15 |
《Multidisciplinary Interventional Oncology》 Book Proposal |
Jian Lu | Zhongda Hospital, Southeast University, China |
| 5 | 14:15-14:40 |
General discussion |
||
| 6 | 14:40-15:00 |
Committee Board Reform |
Chu Hui Zeng | Zhongda Hospital Southeast University, China |
| 7 | 15:00-15:25 |
General discussion |
||
| 8 | 15:25-15:45 |
Non-invasive Assessment of Portal Hypertension for Evaluating the Prognosis of uHCC: An International Multicenter Cohort Study |
Yu-Qing Wang | Zhongda Hospital, Southeast University, China |
| 9 | 15:45-16:10 |
General discussion |
||
| 10 | 16:10-16:30 |
Assessment of liver and spleen stiffness measurement accuracy in predicting the presence of oesophageal varices needing treatment in cirrhotic patients with advanced HCC who undergo systemic therapy |
Xiao-Long Qi | Zhongda Hospital Southeast University, China |
| 11 | 16:30-16:55 |
General discussion |
||
| 12 | 16:55-17:15 |
International Society of Multidisciplinary Interventional Oncology (ISMIO) Expert Consensus Statement on Transarterial Chemoembolization Combined with Immunotherapy-Based Systemic Therapy for Hepatocellular Carcinoma |
Bin-Yan Zhong | Zhejiang Cancer Hospital, China |
| 13 | 17:15-17:40 |
General discussion |
||
| 14 | 17:40-17:50 |
Close Remarks
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
|
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 14:00-14:05 |
Opening Remarks
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
|
||
| 2 | 14:05-14:20 |
NEJM and Clinical Research |
Rui-Ping Xiao | Associate Editor, New England Journal of Medicine, China |
| 3 | 14:20-14:35 |
Why and How to Publish on Med-X Journal? |
Lisa X. Xu | Editors-in-Chief, Med-X, China |
| 4 | 14:35-14:50 |
Trends and Prospects of Sustainable Growth in STTT |
Qiu Sun | Editor, Signal Transduction and Targeted Therapy, China |
| 5 | 14:50-15:05 |
The Innovation Journals: Serving Global Reserchers |
Ke Chen | Executive Director, The Innovation, China |
| 6 | 15:05-15:15 |
Introduction to EngMedicine |
Fu-Gen Wu | Southeast University, China |
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 15:15-15:55 |
Increasing the Proportion of International Submissions |
||
| 2 | 15:15-15:55 |
Enhancing the Quality of Submissions |
||
| 3 | 15:15-15:55 |
Improving Citation Rates and Journal Visibility |
||
| 4 | 15:55-16:00 |
Summary
Xiao-Long Qi
Zhongda Hospital Southeast University, China
|
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 08:00-08:20 |
Precision Treatment of Triple Negative Breast Cancer |
Zhi-Min Shao | Fudan University Affiliated Cancer Hospital, China |
| 2 | 08:20-08:40 |
Use of Artificial Intelligence for Imaging and Therapy of HCC |
Julius Chapiro | Yale School of Medicine, USA |
| 3 | 08:40-09:00 |
Application of Ultra Resolution Microscopy in Tumor Diagnosis and Treatment |
Ping Liang | Chinese PLA General Hospital, China |
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 09:35-09:55 |
Gastroduodenal Stents: Evolution and Future Perspectives |
Ho-Young Song | Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China |
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 10:00-10:20 |
Advancement of Combined Locoregional Therapy with Immunotherapy in HCC |
Gao-Jun Teng | Zhongda Hospital, Southeast University, China |
| 2 | 10:20-10:40 |
New Horizons of Liver Tumor Treatment |
David C. Madoff | Yale School of Medicine, USA |
| 3 | 10:40-11:00 |
Multimodal Thermal Therapy for Solid Tumor: A New Interventional Immunomodulatory |
Lisa X. Xu | Shanghai Jiao Tong University, China |
| 4 | 11:00-11:20 |
Preclinical and Clinical Histotripsy for the Treatment of Liver Cancer |
Maggie (Man) Zhang | University of Michigan, USA |
| 5 | 11:20-11:40 |
Research on the Mechanisms of Cancer Cachexia and Drug Development |
Rui-Ping Xiao | Peking University, China |
| 6 | 11:40-12:00 |
Discussion |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 12:30-12:35 |
Opening Remarks
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
|
||
| 2 | 12:35-12:40 |
Experts Speech
Lian-Xin Liu
The First Affiliated Hospital of University of Science and Technology of China
Ming Kuang The First Affiliated Hospital, Sun Yat-Sen University, China Hua Xiang Hunan Cancer Hospital, China Guo-Hong Han Xi'an International Medical Center Hospital, China Zhong-Min Wang Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China |
||
| 3 | 12:40-12:55 |
Structured Research, Limitless Innovation |
Masatoshi Kudo | Kindai University Faculty of Medicine, Japan |
| 4 | 12:55-13:10 |
laparoscopic liver resection for liver cance |
Lian-Xin Liu | The First Affiliated Hospital of University of Science and Technology of China |
| 5 | 13:10-13:25 |
Panelists
Masatoshi Kudo
Kindai University Faculty of Medicine, Japan
Tian-Qiang Song Tianjin Medical University Cancer Institute & Hospital, China Hai-Tao Zhao Peking Union Medical College Hospital, China Hai-Bo Shao The First Affiliated Hospital of China Meical University, China Jia-Ping Li The First Affiliated Hospital of Sun Yat-sen University, China Ming Zhao Sun Yat-Sen University Cancer Center, China Hai-Peng Yu Tianjin Medical University Cancer Institute & Hospital, China Jian Lu Zhongda Hospital, Southeast University, China Bin-Yan Zhong Zhejiang Cancer Hospital, China Wen-Zhe Fan The First Affiliated Hospital, Sun Yat-Sen University, China |
||
| 6 | 13:25-13:30 |
Summary
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
|
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 13:30-13:42 |
Role of Y90 Radioembolization in Treatment of Large HCCs |
Rickie Lik-Fai Cheng | Princess Margaret Hospital, Hong Kong, China |
| 2 | 13:42-13:54 |
Combination of TACE with Systemic Therapy for Unresectable HCC |
Zhen-Wei Peng | The First Affiliated Hospital, Sun Yat-Sen University, China |
| 3 | 13:54-14:06 |
Advanced Forearm Access for Same Day Radiation Segmentectomy |
Uei Pua | Tan Tock Seng Hospital, Singapore |
| 4 | 14:06-14:18 |
How to Provide More Surgical Opportunities for Patients with HCC Using Minimal Invasive Methods to Increase the Remnant Liver Volume |
Lian-Xin Liu | The First Affiliated Hospital of University of Science and Technology of China |
| 5 | 14:18-14:30 |
Panelists
Tao Peng
The First Affiliated Hospital of Guangxi Medical University, China
Ji Hoon Shin Asan Medical Cente, University of Ulsan College of Medicine, Korea Rickie Lik-Fai Cheng Princess Margaret Hospital, Hong Kong, China Zhen-Wei Peng The First Affiliated Hospital, Sun Yat-Sen University, China Uei Pua Tan Tock Seng Hospital, Singapore Lian-Xin Liu The First Affiliated Hospital of University of Science and Technology of China |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 14:30-14:42 |
Combining TACE with Checkpoint Inhibitors for Intermediate-stage HCC |
David C. Madoff | Yale School of Medicine, USA |
| 2 | 14:42-14:54 |
How to Select 2nd-line Systemic Therapy in Advanced-stage HCC? |
Masatoshi Kudo | Kindai University Faculty of Medicine, Japan |
| 3 | 14:54-15:06 |
First-line TACE with ICIs and VEGF or TKIs for Intermediate-stage HCC: A Target Trial Emulation Study |
Hai-Dong Zhu | Zhongda Hospital, Southeast University, China |
| 4 | 15:06-15:18 |
Is Systemic Therapy Alone Sufficient as Standard Treatment for Advanced Stage HCC? |
Xiao-Dong Wang | Beijing Cancer Hospital, China |
| 5 | 15:18-15:30 |
Panelists
Wan-Guang Zhang
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China
David C. Madoff Yale School of Medicine, USA Masatoshi Kudo Kindai University Faculty of Medicine, Japan Hai-Dong Zhu Zhongda Hospital, Southeast University, China Xiao-Dong Wang Beijing Cancer Hospital, China |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 16:00-16:12 |
Hepatopancreatoduodenectomy for Widespread Hilar Cholangiocarcinoma |
Kiyoshi Hasegawa | Graduate School of Medicine, The University of Tokyo Hospital, Japan |
| 2 | 16:12-16:24 |
Surgical and Multidisciplinary Treatment of Intrahepatic Cholangiocarcinoma |
Feng Shen | Third Affiliated Hospital of Naval Medical University (Shanghai Oriental Hepatobiliary Surgery Hospital), China |
| 3 | 16:24-16:36 |
Intervention for Biliary Malignancy |
Seung Boo Yang | Nowon Eulji University Hospital, Korea |
| 4 | 16:36-16:48 |
Neoadjuvant Therapy for BTC — A Medical Oncologist's Perspective |
Yuan Cheng | Jinling Hospital, Nanjing University, China |
| 5 | 16:48-17:00 |
Panelists
Lian-Xin Liu
The First Affiliated Hospital of University of Science and Technology of China
Hai-Tao Zhao Peking Union Medical College Hospital, China Kiyoshi Hasegawa Graduate School of Medicine, The University of Tokyo Hospital, Japan Feng Shen Third Affiliated Hospital of Naval Medical University (Shanghai Oriental Hepatobiliary Surgery Hospital), China Seung Boo Yang Nowon Eulji University Hospital, Korea Yuan Cheng Jinling Hospital, Nanjing University, China |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 17:00-17:12 |
Percutaneous Biliary Metallic Stent Insertion in Patients with Malignant Duodenobiliary Obstruction: Outcomes and Factors Influencing Biliary Stent Patency |
Hyun Ki Yoon | Asan Medical Center, University of Ulsan College of Medicine, Korea |
| 2 | 17:12-17:24 |
Research Progress and Challenges in Mucosal Melanoma of the Head and Neck |
Wei Guo | Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, China |
| 3 | 17:24-17:36 |
The Value of Integrated Angiography and CT Scan System for Oncologic Interventions |
Kiang Hiong Tay | Singapore General Hospital, Singapore |
| 4 | 17:36-17:48 |
Same Day Percutaneous Renal Cryoablation : A New Paradigm to Enhancing Patient Care? |
Jun-Jian Huang | Emory University school of medicine, USA |
| 5 | 17:48-18:00 |
Cool Approach, Clear Result: Lung Cryoablation in Clinical Practice |
Somrach Thamtorawat | Faculty of Medicine Siriraj Hospital, Thailand |
| 6 | 18:00-18:15 |
Panelists
Alex Tang
Subang Jaya Medical Centre,Malaysia
Wei-Qian Chen Zhejiang Lishui Central Hospital, China Hyun Ki Yoon Asan Medical Center, University of Ulsan College of Medicine, Korea Wei Guo Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, China Kiang Hiong Tay Singapore General Hospital, Singapore Jun-Jian Huang Emory University school of medicine, USA Somrach Thamtorawat Faculty of Medicine Siriraj Hospital, Thailand |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 13:30-13:42 |
Trans-arterial Approach for Treatment of Primary Lung Cancer |
Shinichi Hori | Institute for Image Guided Therapy, Japan |
| 2 | 13:42-13:54 |
Bronchial Artery Embolization in Hemoptysis: Is Glue Better than PVA? |
Ajit K. Yadav | Sir Ganga Ram Hospital, Delhi, India |
| 3 | 13:54-14:06 |
Lung Neoplasms—the Role of TACP, TPCE Combined with Thermoablation: Long-term Evaluation |
Thomas J. Vogl | University Hospital Frankfurt, Johann Wolfgang Goethe University, Germany |
| 4 | 14:06-14:18 |
Current Status of Clinical Application of SBRT in Lung Tumors |
Ya-Ping Xu | Shanghai Pulmonary Hospital, China |
| 5 | 14:18-14:30 |
Panelists
Xiao-Li Zhu
The First Affiliated Hospital of Soochow University, China
Shinichi Hori Institute for Image Guided Therapy, Japan Ajit K. Yadav Sir Ganga Ram Hospital, Delhi, India Thomas J. Vogl University Hospital Frankfurt, Johann Wolfgang Goethe University, Germany Ya-Ping Xu Shanghai Pulmonary Hospital, China |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 14:30-14:42 |
A New Field of Interventional Radiology: Breast Cancer Treatment |
Shinichi Hori | Institute for Image Guided Therapy, Japan |
| 2 | 14:42-14:54 |
Translational Research in Breast Cancers Metabolism |
Hai Hu | Zhejiang Cancer Hospital, China |
| 3 | 14:54-15:06 |
Evolution of Antibody-drug-conjugate Therapy for Breast Cancer |
Masakazu Toi | Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Japan |
| 4 | 15:06-15:18 |
TBD |
Yong-Mei Yin | Jiangsu Province Hospital (The First Affilated Hospital with Nanjing Medical University), China |
| 5 | 15:18-15:30 |
Advances in Breast Cancer Ablation |
Jie Yu | Chinese PLA General Hospital, China |
| 6 | 15:30-15:45 |
Panelists
Yong-Mei Yin
Jiangsu Province Hospital (The First Affilated Hospital with Nanjing Medical University), China
Hai-Peng Yu Tianjin Medical University Cancer Institute & Hospital, China Hai Hu Zhejiang Cancer Hospital, China Masakazu Toi Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Japan Jie Yu Chinese PLA General Hospital, China |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 16:00-16:12 |
Contemporary Management of Locally Advanced Pancreas Cancer |
Flavio G. Rocha | Oregon Health and Science University, USA |
| 2 | 16:12-16:24 |
Precision Management of Pancreatic Cancer in the Era of Multimodal Analysis |
Bai-Yong Shen | Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China |
| 3 | 16:24-16:36 |
High-voltage Pulse Technology: From Fundamental Principles to Comprehensive Applications in Multiple Fields |
Zhong-Min Wang | Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China |
| 4 | 16:36-16:48 |
A Personalised Approach in the Treatment of Pancreatic Cancer |
Alexey Zhao | P. A. Herzen Institute of Oncology, Russia |
| 5 | 16:48-17:00 |
Panelists
Govindarajan Narayanan
Miami Cancer Institute Baptist Health South Florida, USA
Flavio G. Rocha Oregon Health and Science University, USA Bai-Yong Shen Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China Alexey Zhao P. A. Herzen Institute of Oncology, Russia Zhong-Min Wang Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 17:00-17:12 |
Clinical Outcomes of Ablation-osteoplasty-reinforcement-internal Fixation (AORIF) of the Peri-acetabular Metastases from Breast, Lung, Prostate, and Kidney |
Francis Lee | Yale School of Medicine, USA |
| 2 | 17:12-17:24 |
AI-integrated PTA Treatment |
Aichi Chien | David Geffen School of Medicine at UCLA, USA |
| 3 | 17:24-17:36 |
Tips and Tricks for Manipulation of Microcatheter |
Shinichi Hori | Institute for Image Guided Therapy, Japan |
| 4 | 17:36-17:48 |
Transarterial Chemoembolization in the Management of Hepatocellular Carcinoma: An Overview of Global Practices and Emerging Trends |
Tamana Marvin | Philippine Heart Center, Philippines |
| 5 | 17:48-18:00 |
Technology-enhanced Precision in MIS HPB Surgery |
Alfred Kow Wei Chieh | National University Hospital, Singapore |
| 6 | 18:00-18:15 |
Panelists
Song Wang
The Affiliated Hospital of Qingdao University, China
Francis Lee Yale School of Medicine, USA Gao-Feng Shu Zhejiang Lishui Central Hospital, China Aichi Chien David Geffen School of Medicine at UCLA, USA Shinichi Hori Institute for Image Guided Therapy, Japan Tamana Marvin Philippine Heart Center, Philippines Alfred Kow Wei Chieh National University Hospital, Singapore |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 13:30-13:42 |
Emerging Trends in the Treatment of Advanced Hepatocellular Carcinoma: A Radiological Perspective |
Hyun Ki Yoon | Asan Medical Center, University of Ulsan College of Medicine, Korea |
| 2 | 13:42-13:54 |
Value Based Care in IR Treatments of Hepatocellular Carcinoma |
Kiang Hiong Tay | Singapore General Hospital, Singapore |
| 3 | 13:54-14:06 |
MRI-guided Clinically Bacteriplytic Transarterial Embolization for Liver Tumor Therapy |
Zhuo-Li Zhang | University of California, USA |
| 4 | 14:06-14:18 |
Biomaterials to Assist Interventional Cancer Therapies |
Zhuang Liu | Soochow University, China |
| 5 | 14:18-14:30 |
Panelists
Lei Zhang
Sun Yat-sen Memorial Hospital, China
Hong-Shan Zhong China Medical University, China Hyun Ki Yoon Asan Medical Center, University of Ulsan College of Medicine, Korea Kiang Hiong Tay Singapore General Hospital, Singapore Zhuo-Li Zhang University of California, USA Zhuang Liu Soochow University, China |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 14:30-14:42 |
Development and Application of Early Screening and Diagnosis Technology for Gastric Cancer |
Xiang-Dong Cheng | Zhejiang Cancer Hospital, China |
| 2 | 14:42-14:54 |
Advancing Y-90 Dosimetry: Personalized Approaches for Hepatocellular Carcinoma |
Jon C. Davidson | University Hospitals Cleveland Medical Center, USA |
| 3 | 14:54-15:06 |
Surgical Resection with Major Hepatic Vein Reconstruction for Colorectal Liver Metastasis |
Kiyoshi Hasegawa | Graduate School of Medicine, The University of Tokyo Hospital, Japan |
| 4 | 15:06-15:18 |
Ablation of Liver Cancer: Challenges and Developments |
Ming Kuang | The First Affiliated Hospital, Sun Yat-Sen University, China |
| 5 | 15:18-15:30 |
Panelists
Fei Gao
Sun Yat-Sen University Cancer Center, China
Prijo Sidipratomo Dr. Cipto Mangunkusumo National General Hospital, Universitas Indonesia, Indonesia Xiang-Dong Cheng Zhejiang Cancer Hospital, China Jon C. Davidson University Hospitals Cleveland Medical Center, USA Wei-Ling He Xiamen University Affiliated Xiang'an Hospital, China Kiyoshi Hasegawa Graduate School of Medicine, The University of Tokyo Hospital, Japan |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 16:00-16:12 |
Different Response Pattern between IO plus Anti-VEGF and IO plus IO Regimens |
Masatoshi Kudo | Kindai University Faculty of Medicine, Japan |
| 2 | 16:12-16:24 |
Mechanistic Research and Emerging Therapeutic Approaches for Hepatocellular Carcinoma with Pulmonary Metastasis |
Hong Wu | West China Hospital of Sichuan University, China |
| 3 | 16:24-16:36 |
Combining TACE with Checkpoint Inhibitors for Intermediate-Stage HCC |
Jon C. Davidson | University Hospitals Cleveland Medical Center, USA |
| 4 | 16:36-16:48 |
Chinese Experience of Perioperative Management for Liver Cancer |
Hong Zhao | Cancer Institute and Hospital, China |
| 5 | 16:48-17:00 |
Panelists
Hong Wu
West China Hospital of Sichuan University, China
Le-Du Zhou Xiangya Hospital of Central South University, China Masatoshi Kudo Kindai University Faculty of Medicine, Japan Jon C. Davidson University Hospitals Cleveland Medical Center, USA Hong Zhao Cancer Institute and Hospital, China |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 17:00-17:12 |
Multimodal Therapies and Emerging Insights in Colorectal Cancer Liver Metastases |
Wei-Ling He | Xiamen University Affiliated Xiang'an Hospital, China |
| 2 | 17:12-17:24 |
Advancements in Irreversible Electroporation Techniques for Kidney Tumors |
Tze Min Wah | St. James's University Hospital, UK |
| 3 | 17:24-17:36 |
The Evolution of Irreversible Electroporation: Insights from a Decade of Practice |
Govindarajan Narayanan | Miami Cancer Institute Baptist Health South Florida, USA |
| 4 | 17:36-17:48 |
Microwave Ablation for Large Tumors: Techniques to Minimize Recurrence |
Jon C. Davidson | University Hospitals Cleveland Medical Center, USA |
| 5 | 17:48-18:00 |
Panelists
Masakazu Toi
Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Japan
Yong-Yi Zeng The First Affiliated Hospital of Fujian Medical University, China Ming Kuang The First Affiliated Hospital, Sun Yat-Sen University, China Tze Min Wah St. James's University Hospital, UK Govindarajan Narayanan Miami Cancer Institute Baptist Health South Florida, USA Jon C. Davidson University Hospitals Cleveland Medical Center, USA |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 13:30-13:42 |
The Application of AI in HPB Surgery and Oncology |
Alfred Kow Wei Chieh | National University Hospital, Singapore |
| 2 | 13:42-13:54 |
A Duo-targeting Pan-anticancer Strategy with Potential Interventional Applications |
Yi-Cheng Ni | Southeast University, China |
| 3 | 13:54-14:06 |
New Data Showing Vascular Changes in Patients with Diabetes: How to Modify Treatment Strategies |
Aichi Chien | David Geffen School of Medicine at UCLA, USA |
| 4 | 14:06-14:18 |
ALPPS--New Surgical Paradigm to Treat Traditionally-Unresectable Liver Cancer |
Jian Zhou | Zhongshan Hospital, Fudan University, China |
| 5 | 14:18-14:30 |
Panelists
Guang-Hui Luo
Kiang Wu Hospital, Macau, China
Han Wang Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, China Alfred Kow Wei Chieh National University Hospital, Singapore Yi-Cheng Ni Southeast University, China Aichi Chien David Geffen School of Medicine at UCLA, USA Jian Zhou Zhongshan Hospital, Fudan University, China |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 14:30-14:42 |
Lymphangiography and TD Embolization in Latrogenic Chylous Leaks |
Ajit K. Yadav | Sir Ganga Ram Hospital, Delhi, India |
| 2 | 14:42-14:54 |
MRI-guided IRE Combined with DC Vaccination for PDAC Treatment |
Zhuo-Li Zhang | University of California, USA |
| 3 | 14:54-15:06 |
Molecular Imaging Biomarker Development for Combined Immunotherapy and Locoregional Therapy of HCC: From Bench to Bedside |
Julius Chapiro | Yale School of Medicine, USA |
| 4 | 15:06-15:18 |
Comprehensive TAE Strategy for HCC Based on Thermo-Sensitive Nanogels |
Xiang-Liang Yang | Huazhong University of Science and Technology, China |
| 5 | 15:18-15:30 |
Towards Precision Medicine: Multi-modal Image Analysis Driven by Artificial Intelligence |
Yang Wang | Zhejiang Cancer Hospital, China |
| 6 | 15:30-15:45 |
Panelists
Francis Lee
Yale School of Medicine, USA
Rui-Fang Ni The First Affiliated Hospital of Soochow University, China Ajit K. Yadav Sir Ganga Ram Hospital, Delhi, India Zhuo-Li Zhang University of California, USA Xiang-Liang Yang Huazhong University of Science and Technology, China Julius Chapiro Yale School of Medicine, USA Yang Wang Zhejiang Cancer Hospital, China |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 16:00-16:10 |
Opening Remarks
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
|
||
| 2 | 16:10-16:25 |
Cryoablation for Locally Advanced Pancreatic Cancer and Pancreatic Metastasis |
Alexey Zhao | P. A. Herzen Institute of Oncology, Russia |
| 3 | 16:25-16:40 |
Interventional Treatments for Benign and Malignant Breast Masses |
Mehmet Mahir Atasoy | Maltepe University School of Medicine, Turkey |
| 4 | 16:40-16:55 |
Cryoablation in the Prostate |
Saim Yilmaz | Varisson Radiology Center, Turkey |
| 5 | 16:55-17:10 |
The role of Thermal Ablation Methods in the Treatment of HCC in the Republic of Kazakhstan |
Niyaz Malayev | National Scientific Medical Center, Kazakhstan |
| 6 | 17:10-17:25 |
Role of Interventional Radiology in Pain Management of Abdominal Cancer |
Shahzad Bhatti | Mayo Hospital/King Edward Medical University, Pakistan |
| 7 | 17:25-17:40 |
Co-ablation System in Tumor Therapy: Advancements in Composite Cryo-thermal Ablation for Cancer Treatment |
Li-Zhi Niu | Guangzhou Fuda Cancer Hospital, China |
| 8 | 17:40-17:55 |
Discussion
Wei-Jun Fan
Sun Yat-sen University Cancer Center, China
Zhong-Min Wang Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China |
||
| 9 | 17:55-18:00 |
Conference Summary
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
|
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 13:30-13:42 |
New Ice Age of Musculoskeletal Intervention: Role of Percutaneous Cryoablation in Bone and Soft Tissue Tumors |
Jun-Jian Huang | Emory University school of medicine, USA |
| 2 | 13:42-13:54 |
Super-selective TACE |
Seung Boo Yang | Nowon Eulji University Hospital, Korea |
| 3 | 13:54-14:06 |
Optimizing Outcomes in Centrally Located HCC: The Evolving Role of Precision Radiotherapy |
Wei-Hu Wang | Beijing Cancer Hospital, China |
| 4 | 14:06-14:18 |
From Vision to Precision: Image-guided Solutions for Interventional Oncology |
Yu Deuerling Zheng | Siemens Healthineers, Germany |
| 5 | 14:18-14:30 |
Panelists
Hai-Bin Shi
Jiangsu Province Hospital (The First Affilated Hospital with Nanjing Medical University), China
Jun-Jian Huang Emory University school of medicine, USA Seung Boo Yang Nowon Eulji University Hospital, Korea Wei-Hu Wang Beijing Cancer Hospital, China Yu Deuerling Zheng Siemens Healthineers, Germany |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 14:30-14:45 |
Transradial HepaSphere Treatment for HCC in AMC |
Ji Hoon Shin | Asan Medical Cente, University of Ulsan College of Medicine, Korea |
| 2 | 14:45-15:00 |
Combined Immuno-DTACE for Difficult-to-treat Liver Cancer Patients |
Alex Tang | Subang Jaya Medical Centre,Malaysia |
| 3 | 15:00-15:15 |
Advancing Your Practice in Refractory Liver Cancers Management |
Shinichi Hori | Institute for Image Guided Therapy, Japan |
| 4 | 15:15-15:30 |
Discussion
Jia-Ping Li
The First Affiliated Hospital of Sun Yat-sen University, China
Zi-Shu Zhang Xiangya Hospital Central South University, China Hai-Bo Shao The First Affiliated Hospital of China Meical University, China |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 16:00-16:06 |
Does Needle Biopsy Immediately after Percutaneous Microwave and Cryoablation of Lung Neoplasm Affect Pathological Results? A Clinical and Animal Study |
Jun-Ting Ma | First Hospital of China Medical University, China |
| 2 | 16:06-16:12 |
Outcomes of First-line Microwave Ablation of Treatment-naive Epidermal Growth Factor Receptor–mutated Advanced Lung Adenocarcinoma Treated with Tyrosine Kinase Inhibitors |
Sheng Xu | Beijing Hospital, National Center of Gerontology, China |
| 3 | 16:12-16:18 |
Microwave Ablation versus Lobectomy for Ground-glass Opacity Nodules in the Hilar Region: A Multicenter Prospective Real-world Study on Efficacy and Safety |
Jia-Chang Chi | renji hospital, China |
| 4 | 16:18-16:24 |
Cryoablation Enhanced Anti-tumor Immunity and Survival for Patients with Liver Metastatic Melanoma Receiving PD-1 Blockade Therapy: Insights from Longitudinal RNA-seq Data |
Chen Li | Sun Yat-sen University Cancer Center, China |
| 5 | 16:24-16:30 |
Response Evaluation of Liver Directed Therapies for Liver Metastasis in NET |
VARSHA KEDAR | TATA MEMORIAL HOSPITAL, MUMBAI , INDIA |
| 6 | 16:30-16:36 |
Hepatic Arterial Infusion Chemotherapy with or without Hepatic Artery Chemoembolization for Esophageal Carcinoma Patients with Liver Metastasis: A Clinical Retrospective Study |
Mingrui Yan | Peking University Shougang Hospital,Beijing, China |
| 7 | 16:36-16:42 |
Drug Eluting Bead Transarterial Chemoembolization (DTACE) Combined with Hepatic Arterial Infusion Chemotherapy versus DTACE Alone for Hepatocellular Carcinoma in Barcelona Clinic Liver Cancer stage C: A Prospective, Multicenter Analysis |
Daqian Han | The First Affiliated Hospital of Zhengzhou University |
| 8 | 16:42-16:48 |
Comparing Percutaneous and Endoscopic Biliary Drainage in Inoperable Bismuth III/IV Malignant Hilar Biliary Obstruction: Clinical Outcomes and Prognostic Factors |
XIAO-BO FU | Sun Yat-sen University Cancer Center, China |
| 9 | 16:48-16:54 |
Metformin Suppress Liver Cancer Metastasis by Inhibiting Microwave Ablation Therapy Induced EMT through Modulation of the TGF-β-Smad2/3 Signaling Pathway |
Xian-Mei Liu | Affiliated Hospital of Guizhou Medical University, China |
| 10 | 16:54-17:00 |
Health Economics Analysis of Three Treatment Methods for Uterine Fibroids |
Yong Jin | The Second Affiliated Hospital of Soochow University, China |
| 11 | 17:00-17:06 |
Percutaneous Transhepatic Cholangiography in Biliary Obstruction: A Retrospective Audit of Outcomes and Complications |
Sana Sheykhzadeh | Norfolk and Norwich University Hospital |
| 12 | 17:06-17:12 |
Retrospective Analysis of Diagnostic Accuracy of Image-guided Needle Biopsy of Pancreatic Lesions |
Antariksh Vijan | Tata Memorial Hospital, Mumbai, India |
| 13 | 17:12-17:18 |
CCL2⁺ Inflammatory Cancer-associated Fibroblasts Promote Chemoresistance and Tumor Progression in Microsatellite Stable Colorectal Cancer via the CCL2-P4HB-NOTCH-STAT3 Axis |
Si-Yuan Weng | National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, China |
| 14 | 17:18-17:24 |
3D-printed Versatile Biodegradable Biliary Stent with Zinc/Sirolimus for Anti-bacterial and Anti-hyperplasia in a Rabbit Bile Duct |
Jung-Hoon Park | Asan Medical Center, Korea |
| 15 | 17:24-17:30 |
Neoadjuvant Arterial Infusion Chemotherapy versus Intravenous Chemotherapy for Locally Advanced Gastric Cancer: A Long-term Follow-up |
Jun Chen | Zhejiang Provincial People's Hospital, Hangzhou Medical College, China |
| 16 | 17:30-17:36 |
Whether the Choice of Location for Re-implantation Chest Port Affects the Incidence of Complications in Adult Tumor Patients Undergoing Right Chest Port Removal |
Cao-Ye Wang | Changzhou First People Hospital, China |
| 17 | 17:36-17:42 |
Direct Percutaneous Embolization of Hypervascular Renal Cell Cancer Metastasis to the Spine |
Calvin Cheong | National University Hospital, Singapore |
| 18 | 17:42-17:48 |
Long-term Outcomes of Image-guided Ablation and Laparoscopic Partial Nephrectomy for T1 Renal Cell Carcinoma |
Vinson Chan | University of Leeds, United Kingdom |
| 19 | 17:48-17:54 |
The Status of Cytotoxic Lymphocytes Indicate Therapeutic Efficacy and Prognosis in Patients with Advanced Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Combined with Systemic Therapies |
Hai-Feng Zhou | The First Affiliated Hospital of Nanjing Medical University, China |
| 20 | 17:54-18:00 |
Transjugular Intrahepatic Portosystemic Shunt Plus Transarterial Chemoembolization of Hepatocellular Carcinoma Patients with Portal Vein Tumour Thrombus-related Variceal Bleeding |
Wei-Zhong Zhou | The first affiliated hospital of Nanjing medical university, China |
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 13:30-13:35 |
Welcome Address
Sheng-Hong Ju
Zhongda Hospital, Southeast University, China
|
||
| 2 | 13:35-13:40 |
ROADS Launch Ceremony |
||
| 3 | 13:40-14:05 |
How to Evaluate Treatment Response of HCC after Radiation Based Locoregional Treatment: LR-TRA v2024 |
Jeong Min Lee | Seoul National University Hospital, Korea |
| 4 | 14:05-14:30 |
Recent Advances in Image-Guided Locoregional Therapies for HCC (New Navigation Tools, New Devices, New Techniques) |
Roberto Iezzi | Università Cattolica del Sacro Cuore, Italy |
| 5 | 14:30-14:55 |
MRI at 0.05 Tesla: A Computing-powered Point-of-care Imaging Device? |
Ed X. Wu | The University of Hong Kong, China |
| 6 | 14:55-15:20 |
Use of EOB MRI for Imaging of Hepatic Malignancies |
Cher Heng Tan | Tan Tock Seng Hospital, Singapore |
| 7 | 15:20-15:35 |
Coffee Break |
||
| 8 | 15:35-16:00 |
Infiltrative HCC: What Every Radiologist Needs to Recognize and Report |
Sahat Matondang | Cipto Mangunkusumo National General Hospita, Indonesia |
| 9 | 16:00-16:25 |
Hepatocellular Carcinoma beyond Diagnosis: Role of Imaging in Prognostication, Pathology and Genetic Correlation |
Xiao-Yang Liu | The University of Toronto, Canada |
| 10 | 16:25-16:50 |
Imaging Evalution of the Treatment Response after Locoregional Therapy for HCC |
Yuan-Cheng Wang | Zhongda Hospital, Southeast University, China |
| 11 | 16:50-17:30 |
ROADS Abdominal Imaging Case Review Webinar |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 13:30-13:35 |
Opening Speakers
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
Masatoshi Kudo Kindai University Faculty of Medicine, Japan Jian Zhou Zhongshan Hospital, Fudan University, China |
||
| 2 | 13:35-13:40 |
ISMIO Meets APPLE: International Consensus Project on TACE Combined with Targeted Therapy and Immunotherapy for HCC
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
Masatoshi Kudo Kindai University Faculty of Medicine, Japan Jian Zhou Zhongshan Hospital, Fudan University, China Lian-Xin Liu The First Affiliated Hospital of University of Science and Technology of China Feng Shen Third Affiliated Hospital of Naval Medical University (Shanghai Oriental Hepatobiliary Surgery Hospital), China Ming Kuang The First Affiliated Hospital, Sun Yat-Sen University, China Hong Wu West China Hospital of Sichuan University, China |
||
| 3 | 13:40-14:00 |
Panel Discussion: CNLC Meets BCLC: Impact of TACE-Targeted-Immunotherapy Advances on International Guideline Updates: Evidence from Global Trials and Clinical Practice
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
Masatoshi Kudo Kindai University Faculty of Medicine, Japan Jian Zhou Zhongshan Hospital, Fudan University, China Lian-Xin Liu The First Affiliated Hospital of University of Science and Technology of China Feng Shen Third Affiliated Hospital of Naval Medical University (Shanghai Oriental Hepatobiliary Surgery Hospital), China Ming Kuang The First Affiliated Hospital, Sun Yat-Sen University, China Hong Wu West China Hospital of Sichuan University, China |
||
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 08:00-08:12 |
A pilot study for PTMC thermal ablation |
Dong Xu | Zhejiang Cancer Hospital, China |
| 2 | 08:12-08:24 |
Ultrasound-based management of thyroid nodules: state-of-art and perspective |
Hui-Xiong Xu | Zhongshan Hospital, Fudan University, Shanghai, China |
| 3 | 08:24-08:36 |
Ablation of Papillary Microcacinoma |
Mehmet Korkmaz | Evliya Çelebi Training & Research Hospital, Turkey |
| 4 | 08:36-08:48 |
Ablation of Parathyroid Adenomas |
Furkan Erturk Urfali | Bursa City Hospital, Turkey |
| 5 | 08:48-09:00 |
Surgical Perspectives on Thyroid Anatomy and Strategies for Ablative Treatment of Benign and Malignant Tumors |
Ying Zhou | The First Affiliated Hospital of Hebei University of Chinese Medicine, China |
| 6 | 09:00-09:12 |
The Role of URM in the Differential Diagnosis of Benign and Malignant Cervical Lymph Nodes: A Preliminary Study |
Ji-Ye Chen | Zhejiang Cancer Hospital, China |
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 09:30-09:36 |
Preparation of a Composite Nanozyme and Its Sonodynamic Therapy in Bladder Cancer |
Jia-Jia Zheng | Zhejiang Provincial People‘s Hospital, China |
| 2 | 09:36-09:42 |
Trans-arterial Embolisation Prior to Image-guided Ablation for T1b/T2a Renal Masses – A Systematic Review and Meta-analysis |
Aisha Ahmed | University of Leeds |
| 3 | 09:42-09:48 |
Results of Ultrasound Guided Vacuum Assisted Breast Biopsy Treatment for Benign Breast Tumor |
Batmunkh Erdenebulgan | Second state central hospital, Mongolia |
| 4 | 09:48-09:54 |
A Nomogram Predicting Venous Thromboembolism Risk in Primary Liver Cancer Patients |
Jing Xiao | Chongqing University Cancer Hospital, China |
| 5 | 09:54-10:00 |
Breat Thermogram Database Generation to Use AI for Early Breast Cancer Detection |
Bilal Majeed | University of Limerick |
| 6 | 10:00-10:06 |
Irradiation Modulates sEVs-PD-L1 Transport in TNBC's Tumor Immune Microenvironment |
Yuqin Wei | Wuming Hospital of Guangxi Medical University, China |
| 7 | 10:06-10:12 |
A Real-world Survey of 1830 Surviving Patients with Adamantinomatous Craniopharyngioma in China |
Zhi-Xiong Lin | Sanbo Brain Hospital, Capital Medical University, China |
| 8 | 10:12-10:18 |
The Diversity of Arterial Approaches in Delivering Intra-arterial Chemotherapy for Retinoblastoma: Experiences from Indonesia |
Jason Jason | Department of Radiology, Faculty of Medicine, Universitas Indonesia - Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia |
| 9 | 10:18-10:24 |
Comparative Effectiveness of Liquid versus Solid Embolic Agents in Pre-surgical Embolization for Intracranial Tumors: A Systematic Review and Meta-analysis |
Yuhang Zhao | Zhongda Hospital, Medical School, Southeast University, China |
| 10 | 10:24-10:30 |
Percutaneous Catheter Drainage (PCD) as Primary Treatment for Necrotizing Pancreatitis: Clinical Outcomes and Comparative Effectiveness |
Gantulga Vanchinsuren | Second State Center Hospital |
| 11 | 10:30-10:36 |
Analysis of Short and Medium Term Clinical Effect of Prostatic Artery Embolization on Symptomatic Prostatic Hyperplasia |
Shi-Long Han | Tenth People's Hospital of Tongji University, China |
| 12 | 10:36-10:42 |
Role of Sclerotherapy in Patients with Vascular Malformations - A Retrospective Study |
Anand Agrawal | |
| 13 | 10:42-10:48 |
Single-cell RNA Sequencing Identifies the Versican-producing Cells in Tumor Microenvironment of Cervical Cancer |
Meng-Fan Zhang | First Affiliated Hospital of Zhengzhou University, China |
| 14 | 10:48-10:54 |
Multicentre Real World Outcomes of Irreversible Electroporation for Complex Small Kidney Cancers (REWIRED) |
Vinson Chan | University of Leeds, United Kingdom |
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 08:00-08:06 |
CT-Guided Microwave Ablation with Vertebral Augmentation for Spinal Metastases with Posterior Wall Defects |
Kai-Xian Zhang | Tengzhou Central People’s Hospital, China |
| 2 | 08:06-08:12 |
A Novel Silver Nanoparticles-functionalized Stent for the Treatment of Malignant Stricture of Esophagus |
Yan Fu | National cancer hospital, Beijing, China |
| 3 | 08:12-08:18 |
Mitochondrial-Cytosolic Cascade Metabolic Regulation System: A Robust Strategy to Disrupt Multipath Energy Replenishment in Cancer Therapy |
Tian-Ming Wang | Xiangya Hospital, Central South University, China |
| 4 | 08:18-08:24 |
Prevention of Acute Thrombosis with Vascular Endothelium Antioxidative Nanoscavenger |
Yi-Xin Zhong | Southeast University Affiliated Zhongda Hospital, China |
| 5 | 08:24-08:30 |
Idarubicin-loaded Degradable Hydrogel for TACE Therapy Enhances Anti-tumor Immunity in Hepatocellular Carcinoma |
Xiao-Kai Zhang | Henan Cancer Hospital/ Affiliated Cancer Hospital of Zhengzhou University, China |
| 6 | 08:30-08:36 |
The Eight Mitochondrial Metabolism-related Genes as Diagnostic Markers for Abdominal Aortic Aneurysm by Integrating Machine Learning Approach |
Yang Zheng | Chongqing University Cancer Hospital |
| 7 | 08:36-08:42 |
Functionalized Calcium Alginate Microspheres for TACE Immunotherapy via Polarizing Macrophages and Releasing Anti-tumor Immune Exosomes |
Xiao-Ju Guo | Lishui Central Hospital, China |
| 8 | 08:42-08:48 |
Celecoxib and Cisplatin Dual-loaded Microspheres Synergistically Enhance Transarterial Chemoembolization Effect of Hepatocellular Carcinoma |
Xin-Wei Han | The First Affiliated Hospital of Zhengzhou University, China |
| 9 | 08:48-08:54 |
Synergistic Quad-modal Nanoembolics: pH/NIR-Driven Chemo-photothermal Ablation with Immune Reprogramming for HCC |
Wan-Qing Shen | the first affiliated hospital of sun yat-sen university, China |
| 10 | 08:54-09:00 |
Restraining Small Extracellular Vesicles: Dawn of A New Era in Nanomedicine |
Ming Yang | Zhongda Hospital, Southeast University, China |
| 11 | 09:00-09:06 |
Engineered Macrophage Membrane-mimicking Nanodrugs Activate the cGAS/STING Pathway to Reverse the Immune-suppressive Microenvironment Induced by RFA |
Wei-Hua Zhang | Zhongda hospital, Southeast University, China |
| 12 | 09:06-09:12 |
Development and Functional Research of an Irradiation-cytokine Composite Stent for Modulating Immune Microenvironment Reprogramming |
Juan Qin | Zhongda Hospital, Medical School, Southeast University, China |
| 13 | 09:12-09:18 |
Tailored Liposomal Nanomedicine Suppresses Incomplete Radiofrequency Ablation-induced Tumor Relapse by Reprogramming Antitumor Immunity |
Duo Wang | zhongda hospital, southeast university, China |
| 14 | 09:18-09:24 |
Autocatalytic Pyroptosis Agonists Modulate Tumor Metabolism and Enhance TACE Efficacy in HCC Therapy |
Lin-Zhu Zhang | Zhongda Hospiital, Southeast University, China |
| 15 | 09:24-09:30 |
Injectable Hydroxyapatite Radiopaque Microspheres: The Next-generation Material for Cancer Interventional Embolization? |
Yi-Nan Ding | sciences zhejiang cancer hospital, China |
| NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 09:30-09:36 |
First-in-Human Study of an Artificial Intelligence Integrated Robot for Image-Guided, Trans-Thoracic Lung Biopsy under Local Anaesthesia |
Nadia Rojas | Singapore General Hospital, Singapore |
| 2 | 09:36-09:42 |
Cancer-Associated Fibroblasts-Derived SEMA3C Facilitates Colorectal Cancer Liver Metastasis via NRP2-Mediated MAPK Activation. |
Yuyuan Zhang | The First Affiliated Hospital of Zhengzhou University, China |
| 3 | 09:42-09:48 |
Global Interest of Interventional Radiology and Interventional Oncology: A Review of a Decade Using The Google Trends Platform |
Vinson Chan | University of Leeds, United Kingdom |
| 4 | 09:48-09:54 |
Quantification of Habitat Imaging Combined with Peritumoral Microenvironment Evolution for Predicting Extracapsular Extension in Prostatic Cancer |
Ye Xiang | Leshan Hospital,Chengdu University of TCM, China |
| 5 | 09:54-10:00 |
Harmonizing Ancient Wisdom and Modern Technology: Exploring Retrieval-Augmented Generation (RAG) with Large Language Models to Transform Education in Interventional Oncology |
Hassan Magdy | Gastrointestinal Surgery Center, Mansoura University, Egypt |
| 6 | 10:00-10:06 |
Conventional Oral Morphine vs. IV Patient-Controlled Analgesia (IPCA) with Hydromorphone (HM) Continuous Infusion plus Rescue Dose (CIRD) or Bolus-Only (BO) for Severe Cancer Pain: A Randomized Phase III study |
Liyu Su | Fujian Cancer Hospital, China |
| 7 | 10:06-10:12 |
Efficacy Comparison of Liver Venous Deprivation and TACE Combined with Targeted and Immunotherapies in Unresectable Hepatocellular Carcinoma with Insufficient FLR Volume |
Ying Yang | West China Hospital, Sichuan University, China |
| 8 | 10:12-10:18 |
Spatial Transcriptomics Reveals Tryptophan Metabolism Restricting Maturation of Intratumoral Tertiary Lymphoid Structures |
Shuling Chen | The First Affiliated Hospital of Sun Yat-sen University, China |